Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
genomic test
|
| gptkbp:clinicalUtility |
reduce need for surgical lung biopsy
|
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Veracyte
|
| https://www.w3.org/2000/01/rdf-schema#label |
Envisia Genomic Classifier
|
| gptkbp:launched |
2018
|
| gptkbp:marketedAs |
gptkb:Veracyte
|
| gptkbp:regulates |
not FDA approved (as of 2024)
Laboratory Developed Test (LDT) |
| gptkbp:relatedTo |
molecular diagnostics
pulmonology |
| gptkbp:target |
idiopathic pulmonary fibrosis
interstitial lung disease |
| gptkbp:technology |
RNA sequencing
|
| gptkbp:type |
transbronchial lung biopsy
|
| gptkbp:usedFor |
diagnosis of idiopathic pulmonary fibrosis
diagnosis of interstitial lung disease |
| gptkbp:bfsParent |
gptkb:Veracyte
|
| gptkbp:bfsLayer |
7
|